This page shows the latest Alzheimer's Research UK news and features for those working in and with pharma, biotech and healthcare.
If approved, aducanumab will become the first treatment to reduce the clinical decline of Alzheimer’s disease, which affects around six in every ten people with dementia in the UK, according ... to Alzheimer’s Research UK.
Campaign for Alzheimer’s Research UK was the clear winner. The ENGINE MHP team celebrates its win at the virtual awards ceremony. ... It was great fun – and really rewarding to work with such a talented and passionate Alzheimer’s Research UK
Winner: In My Shoes: 24 Hours with Crohn’s or Colitis by Mearns &Pike and Electric Putty for Crohn’s &Colitis UK and Takeda. ... 20. Charitable Campaign of the Year. Sponsored by dna Communications. Winner: Shooting for the Moon: Securing New
Gained conditional approval in China in November. To the surprise of the global Alzheimer’s research community, China approved Shanghai Green Valley Pharmaceuticals' algae-based Alzheimer’s treatment GV-971 last ... November. . When GV-971 (sodium
A three-point decline on the scale is viewed as a clinically significant worsening of Alzheimer’s symptoms. ... Responding to the announcement, Alzheimer's Research UK's director of research Carol Routledge commented: "It’s good to see that drug
Responding the news, Hilary Evans, chief executive of Alzheimer’s Research UK, said that “taking another look at aducanumab is a positive step for all those who took part in the ... At Alzheimer’s Research UK, we are already bringing together
More from news
Approximately 3 fully matching, plus 16 partially matching documents found.
Alzheimer’s Research UK is launching head first into the fight, with a new drive towards therapies that avoid the Abeta route. ... A new company has been created from Alzheimer’s Research UK’s Drug Discovery Alliance, which will build on the work
Led by the British dementia research charity, Alzheimer’s Research UK, it aims to bring together academic researchers with pharma and biotech to accelerate the development of novel treatments. ... Dr Carol Routledge, Director of Research at
Funds need to keep flowing. There are fears that the constant failures in the clinic are going to lead to a drop in investment for Alzheimer’s research. ... The project is a joint £250m investment into dementia research led by the Medical Research
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Contract research organisation and drug discovery business Metrion Biosciences has established a scientific advisory board, which will provide strategic scientific guidance to the company. ... The new board will be chaired by Dr Keith McCullagh,
In his new role, Prof De Strooper will work with the institute's founding partners - the Medical Research Council, Alzheimer's Society and Alzheimer's Research UK - to develop new therapeutics ... The UK research landscape is brimming with talent and
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Roadshows. Medical Strategy &Writing. Market Research. Digital Behaviour &User Research. Strategic Planning. ... Alzheimer’s Research UK. Alzheimer’s Society. Basic Needs. Biogen. Butterfly Scheme. Cardiomyopathy UK.
Though vastly different topics, both meetings included presentations on new approaches to help kick start research in markets. . ... This charitable fund represents collaboration between the Department of Health, Alzheimer’s Research UK () and a
More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.
90TEN is a global healthcare communications consultancy with a mission to make people healthier and happier through life-changing education and...